» Authors » Dvora Shmulewitz

Dvora Shmulewitz

Explore the profile of Dvora Shmulewitz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 68
Citations 1119
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shmulewitz D, Levitin M, Skvirsky V, Vider M, Eliashar R, Mikulincer M, et al.
Psychol Med . 2024 Dec; :1-11. PMID: 39641244
Background: Among those with common mental health disorders (e.g. mood, anxiety, and stress disorders), comorbidity of substance and other addictive disorders is prevalent. To simplify the seemingly complex relationships underlying...
2.
Eliashar R, Zilberstein T, Shmulewitz D, Skvirsky V, Vider M, Lev-Ran S
JAMA Netw Open . 2024 Jul; 7(7):e2423993. PMID: 39046738
Importance: Research has shown evidence of increased substance use (ISU) in populations affected by mass terrorism; however, less is known regarding how psychosocial factors interact to estimate ISU following such...
3.
Livne O, Budney A, Borodovsky J, Shmulewitz D, Walsh C, Struble C, et al.
Am J Drug Alcohol Abuse . 2024 Apr; 50(2):242-251. PMID: 38640463
Cannabis use is increasing among middle-aged and older US adults, populations that are particularly vulnerable to the adverse effects of cannabis. Risks for adverse effects differ by cannabis use patterns,...
4.
Livne O, Mannes Z, McDowell Y, Shmulewitz D, Malte C, Saxon A, et al.
Curr Addict Rep . 2023 Dec; 10(3):441-457. PMID: 38149223
Purpose Of Review: Veterans are a large population that is disproportionately affected by various physical and mental health conditions. The primary aim of this review is to provide a concise...
5.
Shmulewitz D, Eliashar R, Levitin M, Lev-Ran S
Subst Abuse Treat Prev Policy . 2023 Oct; 18(1):58. PMID: 37828494
Background: Substance use is a leading cause of preventable morbidity and mortality worldwide. Population-wide screening for problematic substance use in primary health care may mitigate the serious health and socio-economic...
6.
Walsh C, Gorfinkel L, Shmulewitz D, Stohl M, Hasin D
JAMA Psychiatry . 2023 Oct; 81(1):89-96. PMID: 37819655
Importance: Renewed interest in the clinical potential of hallucinogens may lead people with depression to a generally more positive view of the use of lysergic acid diethylamide (LSD). Therefore, past-year...
7.
Gorfinkel L, Stohl M, Shmulewitz D, Hasin D
J Stud Alcohol Drugs . 2023 Oct; 85(1):92-99. PMID: 37796626
Objective: Underreporting of substance use is a frequent concern about studies based on self-report, but few robust studies have examined the agreement between different methods for capturing self-reported substance use....
8.
Borodovsky J, Struble C, Habib M, Hasin D, Shmulewitz D, Walsh C, et al.
Am J Drug Alcohol Abuse . 2023 Sep; 49(6):733-745. PMID: 37774316
Researchers need accurate measurements of cannabis consumption quantities to assess risks and benefits. Survey methods for measuring cannabis flower and concentrate quantities remain underdeveloped. We examined "grams" and "hits" units...
9.
Chapron S, Kervran C, Da Rosa M, Fournet L, Shmulewitz D, Hasin D, et al.
Drug Alcohol Depend . 2023 Sep; 251:110937. PMID: 37666092
Background: Increased consumption of food that are high in energy and sugar have been pointed as a major factor in the obesity epidemic. Impaired control of food intake and the...
10.
Struble C, Borodovsky J, Habib M, Hasin D, Shmulewitz D, Livne O, et al.
Cannabis Cannabinoid Res . 2023 Aug; 9(6):e1604-e1614. PMID: 37594777
Gender and sex can influence cannabis behaviors and consequences (Cannabis Use Disorder [CUD]). Research typically examines sex and gender independently. Gender analyses often exclude transgender and gender diverse (TGD) populations....